Hyperfine Inc (HYPR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.81-2.83%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · HYPR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 16.5 | 13.6 | 12.9 | 11.0 | 6.8 | 1.5 | 0.3 |
| Cost of Revenues | 8.0 | 6.8 | 7.0 | 6.3 | 5.9 | 2.7 | 0.8 |
| Gross Profit | 8.5 | 6.8 | 5.9 | 4.8 | 0.9 | (1.2) | (0.5) |
| Operating Expenses & Income | |||||||
| R&D Expenses | 15.6 | 17.5 | 22.5 | 22.5 | 28.2 | 25.8 | 14.6 |
| Operating Income | (33.6) | (37.1) | (43.2) | (48.1) | (73.9) | (64.9) | (23.5) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 1.0 | 1.0 | 2.5 | 3.8 | 0.8 | 0.0 | 0.1 |
| EBT, Incl. Unusual Items | (34.9) | (35.6) | (40.7) | (44.2) | (73.2) | (64.9) | (23.4) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (34.9) | (35.6) | (40.7) | (44.2) | (44.2) | (64.9) | (23.4) |
| Per Share | |||||||
| Basic EPS | (0.35) | (0.43) | (0.56) | (0.62) | (1.04) | (17.57) | — |
| Diluted EPS | (0.35) | (0.43) | (0.56) | (0.62) | (1.04) | (17.57) | — |
| Revenue per Share | 0.17 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 99.8 | 81.8 | 72.4 | 71.3 | 70.4 | 3.7 | — |
| Diluted Weighted Avg Shares | 99.8 | 81.8 | 72.4 | 71.3 | 70.4 | 3.7 | — |
| Supplemental | |||||||
| EBITDA | — | — | — | — | (72.9) | (64.1) | (23.2) |
| EBIT | (33.6) | (37.1) | (43.2) | (48.1) | (73.9) | (64.9) | (23.5) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.